JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meewes, C.
Right arrow Articles by Clausen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meewes, C.
Right arrow Articles by Clausen, M.

Molecular Biologic and Scintigraphic Analyses of Somatostatin Receptor-Negative Meningiomas

Christian Meewes, Karl H. Bohuslavizki, Brigitte Krisch, Janka Held-Feindt, Eberhard Henze and Malte Clausen

Department of Dermatology, University of Cologne, Cologne; Department of Nuclear Medicine, University Hospital Eppendorf, Hamburg; and Department of Anatomy and Clinic of Nuclear Medicine, Christian-Albrechts-University, Kiel, Germany



View larger version (102K):

[in a new window]
 
FIGURE 1. Coronal gadolinium-DTPA–enhanced T1-weighted MRI slices of SRS OP4 meningioma (A) and SRS ON4 meningioma (B).

 


View larger version (52K):

[in a new window]
 
FIGURE 2. SRS and 99mTc-DTPA scintigraphy of SRS OP4 meningioma. (A) Planar somatostatin receptor scintigram 4 h after injection of 200 MBq 111In-octreotide in anterior and posterior projection. R = right; L = left; V = ventral; D = dorsal. (B) Corresponding transverse SPECT slice at 4 h. (C) Transverse SPECT slice 1 h after injection of 600 MBq 99mTc-DTPA.

 


View larger version (73K):

[in a new window]
 
FIGURE 3. SRS and 99mTc-DTPA scintigraphy of SRS ON4 meningioma. (A) Planar somatostatin receptor scintigram 4 h after injection of 200 MBq 111In-octreotide in anterior and posterior projection. R = right; L = left; V = ventral; D = dorsal. (B) Corresponding transverse SPECT slice at 4 h. (C) Transverse SPECT slice 1 h after injection of 600 MBq 99mTc-DTPA.

 


View larger version (59K):

[in a new window]
 
FIGURE 4. Ethidium bromide–stained agarose electrophoresis gel after separating RT-PCR amplificates with primers of hsst2 (377 bp) and hß-actin (650 bp) from 4 SRS OP1–OP4 meningiomas (top) and 4 SRS ON1–ON4 meningiomas (bottom). Control reactions were performed by omitting RNA. Sizes (bp) of marker fragments are indicated (left lane, top; left and right lanes, bottom).

 


View larger version (129K):

[in a new window]
 
FIGURE 5. Immunocytochemical visualization of somatostatin receptor subtype 2 on surface of OP4 (A) and ON4 (B) cultivated cells. Control reactions were performed by preincubating primary antibody with surplus of its antigenic peptide, OP4 (C) or ON4 (D). (x170)

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.